1st Quarter - Report

WINNING STRATEGIES WASHINGTON for NOVARTIS

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

FY10 Department of Defense Appropriations

LobbyistCovered position, as disclosed
ALEX DELPIZZO —
MICHAEL A MEROLA —
DONNA MULLINS —
ROBERT ZUCKER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Patient Protection and Innovative Biologic Medicines Act of 2009 H.R. 1427and H.R. 1548 Affordable Biologics for Consumers

LobbyistCovered position, as disclosed
ALEX DELPIZZO —
MICHAEL A MEROLA —
DONNA MULLINS —
ROBERT ZUCKER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1427 (111th), H.R. 1548 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.